IPO Webinar on Patent Prosecution After Akamai from www.patentdocs.org The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Patent Prosecution After Akamai: Exploring the Contours of 'Control and Direction'" on October 29, 2015 from 2:00 to 3:00 pm (ET ...
Share via E–mail | Twitter | Facebook
Webinar on Use of Provisional Patent Applications under First-to-File System from www.patentdocs.org Strafford will be offering a webinar/teleconference entitled "Provisional Patent Applications: Preserving IP Rights -- Assessing Whether to Use and Strategies to Leverage Provisional Applications Under the First-to-File System" on October 29, 2015 from 1:00 ...
Share via E–mail | Twitter | Facebook
Webinar on Leveraging Experts During Prosecution and at PTAB from www.patentdocs.org Strafford will be offering a webinar/teleconference entitled "Leveraging Experts for USPTO Prosecution and PTAB -- Developing Strong Patentability Records to Strengthen Claims Against IPR and PGR Challenges" on November 12, 2015 from 1:00 to ...
Share via E–mail | Twitter | Facebook
Webinar on Objective Evidence in IPRs from www.patentdocs.org Strafford will be offering a webinar/teleconference entitled "Objective Evidence in IPRs: Demonstrating Sufficient Nexus -- Linking Evidence and Merits of Claimed Invention, Leveraging Prosecution Declarations" on November 5, 2015 from 1:00 to 2:30 ...
Share via E–mail | Twitter | Facebook
CBS Sunday Morning on October 25, 2015 from ipbiz.blogspot.com Of note in the news portion, Osgood
referenced the event at the University of
Oklahoma, rather than Oklahoma State
University.
An inserted factoid was that pumpkins come in white,
blue, and green.
Almanac was on ...
Share via E–mail | Twitter | Facebook
When is a Covenant-Not-to-Sue a Patent License? from patentlyo.com Meso v. Roche (Meso Scale petition & app) In a new petition for cert, Meso Scale asks the following simple question: Whether a covenant, promise, or agreement not to sue for the infringement of a federal ...
Share via E–mail | Twitter | Facebook